TickerFacts.

BridgeBio Pharma, Inc. (BBIO): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$2.09B
As of 2025-12-31
-$2.52B
As of 2026-06-30
$408.45M2017-12-31: $85.85M2018-12-31: $314.88M2019-12-31: $408.45M2020-12-31: $57.91M2021-12-31: -$870.41M2022-12-31: -$1.25B2023-12-31: -$1.35B2024-12-31: -$1.47B2025-12-31: -$2.09B-$2.09B
2017-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$2.09Bn/m2026-02-24, Balance as of period end
2024-12-31-$1.47Bn/m2026-02-24, Balance as of period end
2023-12-31-$1.35Bn/m2025-02-20, Balance as of period end
2022-12-31-$1.25Bn/m2024-02-22, Balance as of period end
2021-12-31-$870.41Mn/m2023-02-23, Balance as of period end
2020-12-31$57.91M-85.8%2022-02-25, Balance as of period end
2019-12-31$408.45M+29.7%2021-02-25, Balance as of period end
2018-12-31$314.88M+266.8%2020-03-03, Balance as of period end
2017-12-31$85.85Mn/a2020-03-03, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
BridgeBio Pharma, Inc. (BBIO)2025-12-31-$2.09Bn/m
Travere Therapeutics, Inc. (TVTX)2025-12-31$114.83M+94.4%
Mirum Pharmaceuticals, Inc. (MIRM)2025-12-31$314.69M+39.5%
Nature's Sunshine Products Inc (NATR)2025-12-31$161.55M+0.3%
HUTCHMED (China) Ltd (HCM)2025-12-31$1.25B+62.1%
Zai Lab Ltd (ZLAB)2025-12-31$715.50M-14.9%
Organogenesis Holdings Inc. (ORGO)2025-12-31$300.13M+14.2%
Insmed Inc (INSM)2025-12-31$738.98M+158.9%
Opko Health, Inc. (OPK)2025-12-31$1.27B-7.1%

Compare BBIO, TVTX, MIRM, NATR side by side · Screen every company in Pharmaceutical Preparations ↗